» Articles » PMID: 30443679

Elevated Monocyte-specific Type I Interferon Signalling Correlates Positively with Cardiac Healing in Myocardial Infarct Patients but Interferon Alpha Application Deteriorates Myocardial Healing in Rats

Abstract

Monocytes are involved in adverse left ventricular (LV) remodelling following myocardial infarction (MI). To provide therapeutic opportunities we aimed to identify gene transcripts in monocytes that relate to post-MI healing and evaluated intervention with the observed gene activity in a rat MI model. In 51 MI patients treated by primary percutaneous coronary intervention (PCI), the change in LV end-diastolic volume index (EDVi) from baseline to 4-month follow-up was assessed using cardiovascular magnetic resonance imaging (CMR). Circulating monocytes were collected at day 5 (Arterioscler Thromb Vasc Biol 35:1066-1070, 2015; Cell Stem Cell 16:477-487, 2015; Curr Med Chem 13:1877-1893, 2006) after primary PCI for transcriptome analysis. Transcriptional profiling and pathway analysis revealed that patients with a decreased LV EDVi showed an induction of type I interferon (IFN) signalling (type I IFN pathway: P value < 0.001; false discovery rate < 0.001). We subsequently administered 15,000 Units of IFN-α subcutaneously in a rat MI model for three consecutive days following MI. Cardiac function was measured using echocardiography and infarct size/cardiac inflammation using (immuno)-histochemical analysis. We found that IFN-α application deteriorated ventricular dilatation and increased infarct size at day 28 post-MI. Moreover, IFN-α changed the peripheral monocyte subset distribution towards the pro-inflammatory monocyte subset whereas in the myocardium, the presence of the alternative macrophage subset was increased at day 3 post-MI. Our findings suggest that induction of type I IFN signalling in human monocytes coincides with adverse LV remodelling. In rats, however, IFN-α administration deteriorated post-MI healing. These findings underscore important but also contradictory roles for the type I IFN response during cardiac healing following MI.

Citing Articles

The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases.

Wang M, Zhao Y, Liu J, Fan R, Tang Y, Guo Z Acta Pharmacol Sin. 2024; 45(10):1997-2010.

PMID: 38822084 PMC: 11420349. DOI: 10.1038/s41401-023-01185-5.


The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.

Oduro P, Zheng X, Wei J, Yang Y, Wang Y, Zhang H Acta Pharm Sin B. 2022; 12(1):50-75.

PMID: 35127372 PMC: 8799861. DOI: 10.1016/j.apsb.2021.05.011.


Nurr1 Promotes Lung Cancer Apoptosis Via Enhancing Mitochondrial Stress and p53-Drp1 Pathway.

Zhao S, Li P, Wang P, Yang J, Song P, Zhang D Open Life Sci. 2021; 14:262-274.

PMID: 33817160 PMC: 7874811. DOI: 10.1515/biol-2019-0030.


Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success.

Silvis M, Kaffka Genaamd Dengler S, Odille C, Mishra M, Van der Kaaij N, Doevendans P Front Immunol. 2020; 11:599511.

PMID: 33363540 PMC: 7752942. DOI: 10.3389/fimmu.2020.599511.


Mitochondrial quality control mechanisms as molecular targets in cardiac ischemiareperfusion injury.

Wang J, Zhou H Acta Pharm Sin B. 2020; 10(10):1866-1879.

PMID: 33163341 PMC: 7606115. DOI: 10.1016/j.apsb.2020.03.004.


References
1.
Meyer I, Jungmann A, Dieterich C, Zhang M, Lasitschka F, Werkmeister S . The cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction. EMBO Mol Med. 2017; 9(9):1279-1293. PMC: 5582413. DOI: 10.15252/emmm.201707565. View

2.
MANNERING G, Deloria L . The pharmacology and toxicology of the interferons: an overview. Annu Rev Pharmacol Toxicol. 1986; 26:455-515. DOI: 10.1146/annurev.pa.26.040186.002323. View

3.
Maiwald S, Zwetsloot P, Sivapalaratnam S, Dallinga-Thie G . Monocyte gene expression and coronary artery disease. Curr Opin Clin Nutr Metab Care. 2013; 16(4):411-7. DOI: 10.1097/MCO.0b013e32836236f9. View

4.
Bracci L, La Sorsa V, Belardelli F, Proietti E . Type I interferons as vaccine adjuvants against infectious diseases and cancer. Expert Rev Vaccines. 2008; 7(3):373-81. DOI: 10.1586/14760584.7.3.373. View

5.
van der Laan A, Horst E, Delewi R, Begieneman M, Krijnen P, Hirsch A . Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2013; 35(6):376-85. PMC: 3916776. DOI: 10.1093/eurheartj/eht331. View